HYFINITY INVESTMENTS
Huiding Investment brings together a team of senior partners in China's top investment institutions, and is built by a team with years of experience in entrepreneurial operations, overseas technology China's experience and industry resources. Huiding is committed to integrating global medical technology innovation, focusing on the upgrading of China's medical industry, pooling resources, helping each other, and supporting Chinese companies to become industry leaders.
HYFINITY INVESTMENTS
Industry:
E-Commerce
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx PHP Apple Mobile Web App Capable Apple Mobile Web App Status Bar Style Alibaba Baidu Analytics
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-05-15 | Immunowake | Hyfinity Investments investment in Series A - Immunowake | 20 M USD |
2022-05-08 | InxMed | Hyfinity Investments investment in Series B - InxMed | 15 M USD |
2021-12-14 | Cargene | Hyfinity Investments investment in Seed Round - Cargene | 19.2 M USD |
2021-11-01 | Carcell Biopharma | Hyfinity Investments investment in Seed Round - Carcell Biopharma | 100 M CNY |
2021-05-04 | Oculis | Hyfinity Investments investment in Series C - Oculis | 57 M USD |
2019-12-28 | Elpiscience Biopharmaceuticals | Hyfinity Investments investment in Series B - Elpiscience Biopharmaceuticals | 100 M USD |
2019-02-26 | Surgerii Technology | Hyfinity Investments investment in Series A - Surgerii Technology | N/A |
2018-12-25 | Hexaell Biotech | Hyfinity Investments investment in Series A - Hexaell Biotech | 7.27 M USD |
2017-09-27 | ipharmacare | Hyfinity Investments investment in Series C - ipharmacare | 30 M CNY |
More informations about "Hyfinity Investments"
Hyfinity Investments - hyfinityfund.com
Hyfinity Investments are led by senior partners from top-tier investment institutions in China, with years of experiences in healthcare investment, local โฆSee details»
Hyfinity Investments - Crunchbase Investor Profile & Investments
Hyfinity Investments is an investment Firm. Huiding Investment brings together a team of senior partners in China's top investment institutions, and is built by a team with years of experience โฆSee details»
Hyfinity Investments investment portfolio - PitchBook
Apr 4, 2023 Hyfinity Investments's latest investment was on 02-Apr-2024 in Delova Biotech, a company within the Drug Discovery industry. Data โฆSee details»
Hyfinity Investments
Established in 2017, the firm operates the Hyfinity Dacheng RMB Fund, which is based in Ningbo. Hyfinity Investments brings together a team of experienced professionals from leading โฆSee details»
Hyfinity Investments - VC Firm Profile - Gaebler.com Venture โฆ
Hyfinity Investments are led by senior partners from top-tier investment institutions in China, with years of experiences in healthcare investment, local operation, and overseas licensing. โฆSee details»
Hyfinity Investments - raizer.app
Hyfinity Investments is an investment Firm. Learn which startups Hyfinity Investments invests in, number of investmenst, exits, and contact info to pitch your startup. Home Investors Startups. โฆSee details»
Hyfinity Investments - CB Insights
May 9, 2022 Hyfinity Investments devote to advance the global innovations, focus on upgrading of medical industry in China, depending on rich of clinical experience and industry resources. โฆSee details»
Hyfinity Investments (investor) | Nordic 9
Hyfinity Investments is a China-based health- and life science focused investor, aiming to advance the global innovations in partnerships with high unmet needs and rich clinical โฆSee details»
Hyfinity Investments โ Investors Database - Unicorn Nest
Hyfinity Investments. www.hyfinityfund.com. SAVE. Total investments. 11. Average round size. 24M. Portfolio companies. 11. Lead investments. 4. ... Moreover, a startup needs to be at the โฆSee details»
Sylvia Xin He (Hyfinity Investments (CN)) - life-sciences-asia.com
Hyfinity Investments is led by senior partners from top-tier investment institutions in China, with years of experience in healthcare investment, local operation, and overseas licensing. Hyfinity โฆSee details»
ๆฑ้ผๅป็ๆ่ตๅฎ็ฝ
ๆฑ้ผๆ่ตๆฑ่ไธญๅฝ้กถๅฐๆ่ตๆบๆ้ซ็บงๅไผไบบๅข้๏ผ็ฑๆฅๆๅคๅนดๅไธ่ฟ่ฅ็ป้ช๏ผๆตทๅคๆๆฏไธญๅฝ่ฝๅฐ็ป้ชๅ่กไธๅนณๅฐๆง่ตๆบ็ๅข้ๅพๅๆ้ ใๆฑ้ผ่ดๅไบๆดๅๅ จ็ๅป โฆSee details»
Elpiscience Biopharma. (12/28/19). "Press Release: Elpiscience ...
Hyfinity Investments is led by senior partners from top-tier investment institutions in China, with years of experience in healthcare investment, local operation, and overseas licensing. Hyfinity โฆSee details»
InxMed Raised $15 million in Series B+ Financing to Advance โฆ
Hyfinity Investments are led by senior partners from top-tier investment institutions in China, with years of experiences in healthcare investment, local operation, and overseas licensing. โฆSee details»
Hyfinity Investments - Investments, Portfolio & Company Exits
How many investments has this organization made over time? Show . Which industries has this organization most actively invested in? Show . Announced Date . Organization Name ...See details»
Elpiscience Completes Series B Financing of USD $100 Million
Hyfinity Investments is led by senior partners from top-tier investment institutions in China, with years of experience in healthcare investment, local operation, and overseas licensing. Hyfinity โฆSee details»
Oculis Announces an Oversubscribed US$57 million Series C โฆ
May 4, 2021 The round was co-led by new investors BVCF Management and Hyfinity Investments, with VI Partners and Wille AG joining the companyโs existing investors, Bay City โฆSee details»
Immunowake closes $20M in pre-Series A โ immunowake
May 15, 2022 Hyfinity Investments will join the board of directors as part of the financing. The funds raised in this round will be used to accelerate our cytokine pipeline through pre-IND โฆSee details»
Carcell Biopharma closes an oversubscribed financing round led โฆ
Advancing the next generation of cell and gene therapies via a "platform of platforms" modelSINGAPORE, Nov. 1, 2021 -- Carcell Biopharma ("Carcell", the "Company") announced โฆSee details»
Hyfinity Investments - Contacts, Employees, Board Members, โฆ
Hyfinity Investments has 1 current employee profile, Managing Partner and Founder Dr. Sylvia Xin He. Contacts. Edit Contacts Section. We're working on getting contact data for Hyfinity โฆSee details»
Dr. Sylvia Xin He - Managing Partner and Founder @ Hyfinity โฆ
Xin He is the Managing Partner and founder of Hyfinity Investments. Prior to founding Huiding Investment, she was a senior partner at CDH Investments. ... Number of Partner Investments โฆSee details»